Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PPDI Top 100 Drugs > 1. Antihypertensives > Flashcards

1. Antihypertensives Flashcards

1
Q

Norvasc™

Pharmacologic Category

A

Amlodipine

Calcium Channel Blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Norvasc™

FDA Approved Indications/Uses

A

Amlodipine

  • Coronary Artery Disease (CAD)
  • Hypertension (HTN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Norvasc™

Adverse Effects

A
  • Abdominal pain
  • Dizziness
  • Fatigue
  • Flushing
  • Headache
  • Nausea
  • Palpitations
  • Peripheral edema
  • Somnolence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Norvasc™

Dosage Forms

A
  • Tablets
    • 2.5mg
    • 5mg
    • 10mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Norvasc™

Patient Education

A
  • Patient should avoid activities requiring coordination until drug effects are realized, as drug may cause dizziness.
  • Instruct patient to report signs/symptoms of exacerbation of angina or myocardial infarction with initiation and increase in dose.
    • Patients with severe cardiovascular disease have an increased risk.
  • Instruct patient to take a missed dose as soon as possible, but if it has been more than 12 hours since the dose was missed,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tenormin™

Pharmacologic Category

A

Atenolol

Beta Blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tenormin™

FDA Approved Indications/Uses

A

Atenolol

  • Acute Myocardial Infarction
  • Angina
  • Hypertension (HTN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tenormin™

Adverse Effects

A

Atenolol

  • Bradyarrhythmia
  • Cold extremities
  • Depression
  • Dizziness
  • Fatigue
  • Hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tenormin™

Dosage Forms

A

Atenolol

  • Tablet:
    • 25mg
    • 50mg
    • 100mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tenormin™

Patient Education

A

Atenolol

  • Patient should avoid activities requiring mental alertness or coordination until drug effects are realized, as drug may cause dizziness.
  • Advise patient to report signs/symptoms of cardiac failure.
  • Advise patient against sudden discontinuation of drug especially when being treated for angina.
    • Abrupt withdrawal may cause rebound angina.
  • Patient should take drug on an empty stomach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Coreg™

Pharmacologic Category

A

Carvedilol

Alpha-/Beta-Adrenergic Blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Coreg™

FDA Approved Indications/Uses

A

Carvedilol

  • Hypertension (HTN)
  • Heart failure
  • Impaired left ventricular fusion—myocardial infarction (MI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Coreg™

Adverse Effects

A

Carvedilol

  • Bradyarrhythmia
  • Hypotension
  • Peripheral edema
  • Abnormal weight gain
  • Hyperglycemia
  • Diarrhea
  • Dizziness
  • Erectile dysfunction
  • Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coreg™

Dosage Forms

A

Carvedilol

  • Tablet
    • 3.125mg
    • 6.25mg
    • 12.5mg
    • 25mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Coreg™

Patient Education

A

Carvedilol

  • Patient should avoid activities requiring coordination until drug effects are realized, as drug may cause dizziness.
  • This drug may cause diarrhea, nausea, vomiting, arthralgia, back pain, myalgia, headache, vision disorder, erectile dysfunction, reduced libido, or fatigue.
  • Instruct patient to report signs/symptoms of adverse cardiovascular effects such as hypotension (especially in elderly patients), arrhythmias, syncope, palpitations, angina, or edema.
  • Drug may mask symptoms of hypoglycemia. Advise diabetic patients to carefully monitor blood sugar levels.
  • Patient should take drug with food.
  • Advise patient against sudden discontinuation of drug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cardizem™

Pharmacologic Category

A

Diltiazem

Calcium Channel Blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cardizem™

FDA Approved Indications/Uses

A

Diltiazem

  • Atrial arrythmia
  • Hypertension
  • Paroxysmal supraventricular tachycardia
  • Stable angina, chronic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cardizem™

Adverse Effects

A

Diltiazem

  • Bradyarrhythmia
  • Peripheral edema
  • Dizziness
  • Headache
  • Cough
  • Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cardizem™

Dosage Forms

A

Diltiazem

  • Tablet
    • 30mg
    • 60mg
    • 90mg
    • 120mg
  • ER Tablets
    • 180mg
    • 240mg
    • 300mg
    • 360mg
    • 420
  • Capsules
  • IV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cardizem™

Patient Education

A

Diltiazem

  • Patient should avoid activities requiring coordination until drug effects are realized, as drug may cause dizziness.
  • This drug may cause gingival hyperplasia, headache, or dermatologic reactions such as exfoliative dermatitis (reddened skin, skin peeling/flaking) or erythema multiforme (flu-like symptoms, spreading red rash, may progress to more severe form with blistering).
  • Instruct patient to report symptomatic hypotension, bradyarrhythmia, peripheral edema, or syncope.
  • Advise patient against sudden discontinuation of drug.
  • This drug is available in multiple brand names with varying properties by brand. Instruct patient to follow administration instructions specific to the prescribed brand with regards to meals and timing.
  • Patient should avoid concomitant use of beta-blockers or digitalis during drug therapy, unless otherwise directed by healthcare professional.
  • Patient should not drink alcohol while taking this drug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lasix™

Pharmacologic Category

A

Furosemide

  • Diuretic
  • Anthranilic Acid Derivative
22
Q

Lasix™

FDA Approved Indications/Uses

A

Furosemide

  • Congestive heart failure – edema
  • Edema
  • Renal failure – edema
  • Hypertension
  • Pulmonary embolism, acute; adjunct
23
Q

Lasix™

Adverse Effects

A

Furosemide

  • Hyperuricemia
  • Hypomagnesemia
  • Loss of appetite
  • Spasm of bladder
24
Q

Lasix™

Dosage Forms

A

Furosemide

  • Tablet
    • 20mg
    • 40mg
    • 80mg
25
Q

Lasix™

Patient Education

A

Furosemide

  • Drug causes sun-sensitivity. Advise patient to use sunscreen and avoid tanning beds.
  • Patient should avoid activities requiring coordination until drug effects are realized, as drug may cause dizziness, vertigo, or blurred vision.
  • This drug may cause hyperglycemia, hyperuricemia, constipation, diarrhea, loss of appetite, nausea, vomiting, purpuric disorder, cramps, spasticity, asthenia, headache, paresthesia, or scaling eczema.
  • Instruct patient to report unusual bleeding/bruising or signs/symptoms of hypotension, infection, pancreatitis, or ototoxicity (tinnitus, hearing impairment).
  • Advise patient to report signs/symptoms of a severe skin reactions (flu-like symptoms, spreading red rash, or skin/mucous membrane blistering) or erythema multiforme.
  • Instruct patient to eat high-potassium foods during drug therapy, as directed by healthcare professional.
  • Patient should not drink alcohol while taking this drug.
26
Q

Microzide™

Pharmacologic Category

A

Hydrochlorothiazide

Diuretic

27
Q

Microzide™

FDA Approved Indications/Uses

A

Hydrochlorothiazide

  • Edema; adjunct
  • Hypertension
28
Q

Microzide™

Adverse Effects

A

Hydrochlorothiazide

  • Hypotension
  • Phototoxicity
  • Vertigo
29
Q

Microzide™

Dosage Forms

A

Hydrochlorothiazide

  • Capsule
    • 12.5mg
  • Tablet
    • 12.5mg
    • 25mg
    • 50mg
30
Q

Microzide™

Patient Education

A

Hydrochlorothiazide

  • Warn patient to avoid activities requiring mental alertness or coordination until drug effects are realized, as drug may cause blurred vision, vertigo, or dizziness.
  • Drug may cause electrolyte imbalances (hyperuricemia, hyponatremia, hypercalcemia), constipation, diarrhea, nausea, vomiting, paresthesias, muscle spasm, photosensitivity, rash, restlessness, or impotence.
  • Advise patient to report signs/symptoms of acute transient myopia associated with acute angle-closure glaucoma, including sudden ocular pain or decreased visual acuity.
  • Counsel diabetic patient to monitor for signs/symptoms of hyperglycemia and to report difficulties with glycemic control.
  • Tell patient to maintain adequate hydration, especially with exercise, sweating, diarrhea, or vomiting.
  • Advise patient to report signs/symptoms of hypotension, hypokalemia, or hypomagnesemia.
  • Instruct patient to avoid alcohol while taking drug as orthostatic hypotension may be aggravated.
  • Warn patient that there are multiple significant drug-drug interactions for this drug and to consult a healthcare professional prior to new drug use (including over-the-counter and herbal drugs).
31
Q

Prinivil™

Pharmacologic Category

A

Lisinopril

ACE Inhibitor

32
Q

Prinivil™

FDA Approved Indications/Uses

A

Lisinopril

  • Acute myocardial infarction
  • Heart failure; adjunct
  • Hypertension
33
Q

Prinivil™

Adverse Effects

A

Lisinopril

  • Chest pain
  • Hypotension
  • Syncope
  • Dizziness
  • Headache
  • Cough
34
Q

Prinivil™

Dosage Forms

A

Lisinopril

  • Tablet
    • 2.5mg
    • 5mg
    • 10mg
    • 20mg
    • 30mg
    • 40mg
35
Q

Prinivil™

Patient Education

A

Lisinopril

  • This drug may cause nausea, vomiting, dizziness, headache, or angioedema of face, lips, throat, or intestines.
  • Instruct patient to report signs/symptoms of hypotension, or a persistent cough.
  • Advise patient against sudden discontinuation of drug.
36
Q

Cozaar™

Pharmacologic Category

A

Losartan

Angiotensin II Receptor Blocker

37
Q

Cozaar™

FDA Approved Indications/Uses

A

Losartan

  • Cerebrovascular accident
    • In hypertensive patients with left ventricular hypertrophy, prophylaxis
  • Diabetic neuropathy
    • T2DM
    • History of hypertension
  • Hypertension
38
Q

Cozaar™

Adverse Effects

A

Losartan

  • Backache
  • Dizziness
  • Cough
  • Nasal congestion
  • Upper respiratory infection
39
Q

Cozaar™

Dosage Forms

A

Losartan

  • Tablet
    • 25mg
    • 50mg
    • 100mg
40
Q

Cozaar™

Patient Education

A

Losartan

  • Warn female patient to avoid pregnancy and to report a pregnancy that occurs during therapy.
  • Side effects may include dizziness, upper respiratory infection, nasal congestion, and back pain.
  • Warn patient to avoid use of potassium supplements or potassium-containing salt substitutes unless they consult healthcare provider.
41
Q

Lopressor™

Pharmacologic Category

A

Metoprolol tartrate

Beta-Adrenergic Blocker

42
Q

Lopressor™

FDA Approved Indications/Uses

A

Metoprolol tartrate

  • Acute myocardial infarction
  • Angina pectoris
  • Hypertension
43
Q

Lopressor™

Adverse Effects

A

Metoprolol tartrate

  • Bradyarrhythmia
  • Hypotension
  • Dizziness
44
Q

Lopressor™

Dosage Forms

A

Metoprolol tartrate

  • Tablet
    • 25mg
    • 37.5mg
    • 50mg
    • 75mg
    • 100mg
  • IV
    • 1mg/ml
45
Q

Lopressor™

Patient Education

A

Metoprolol tartrate

  • Patient should avoid activities requiring coordination until drug effects are realized, as drug may cause dizziness.
  • This drug may cause diarrhea, depression, or fatigue.
  • Advise patient to report signs/symptoms of cardiac failure. This drug may precipitate or exacerbate cardiac failure in CHF patients.
  • Tell patient to report signs/symptoms of arrhythmias or hypotension.
  • Drug may mask symptoms of hypoglycemia. Advise diabetics to report difficulties with glycemic control.
  • Patient should take extended-release tablet with or immediately following meals.
  • Advise patient against sudden interruption or discontinuation of drug, as this may exacerbate angina or cause myocardial infarction. Sudden discontinuation by patients with thyrotoxicosis may precipitate thyroid storm.
  • Instruct patient to take a missed dose as soon as possible, but if next dose is in less than 4 h, skip the missed dose.
46
Q

Aldactone™

Pharmacologic Category

A

Spironolactone

Renal Competitive Aldosterone Antagonist

47
Q

Aldactone™

FDA Approved Indications/Uses

A

Spironolactone

  • Cirrhosis of liver—edema
  • Edema—nephrotic syndrome
  • Heart failure
    • NYHA Class III or IV
  • Hyperaldosteronism
  • Hypertension; add-on therapy
48
Q

Aldactone™

Adverse Effects

A

Spironolactone

  • Gynecomastia
  • Diarrhea
  • Nausea
  • Vomiting
  • Somnolence
  • Disorder of menstruation
  • Erectile dysfunction
49
Q

Aldactone™

Dosage Forms

A

Spironolactone

  • Tablet
    • 25mg
    • 50mg
    • 100mg
50
Q

Aldactone™

Patient Education

A

Spironolactone

  • Warn patient to report dehydration, hypotension, or symptoms of worsening renal function.
  • Counsel male patient to report gynecomastia.
  • Side effects may include diarrhea, nausea, vomiting, abdominal cramping, fever, leg cramps, lethargy, mental confusion, decreased libido, irregular menses, and rash.
  • Suspension: Tell patient to take drug consistently with respect to food, either before or after a meal.
  • Advise patient to avoid potassium supplements and foods containing high levels of potassium, including salt substitutes.

PPDI Top 100 Drugs (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions